uniQure N.V [QURE] stock is trading at $16.18, up 2.53%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The QURE shares have gain 21.84% over the last week, with a monthly amount glided 6.45%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
uniQure N.V [NASDAQ: QURE] stock has seen the most recent analyst activity on August 14, 2025, when Mizuho upgraded its rating to a Outperform but kept the price target unchanged to $30 for it. On December 10, 2024, upgrade upgraded it’s rating to Strong Buy. Goldman downgraded its rating to a Neutral but $8 remained the price target by the analyst firm on February 29, 2024. Mizuho downgraded its rating to Neutral for this stock on December 19, 2023, and downed its price target to $10. In a note dated March 17, 2022, UBS upgraded an Buy rating on this stock but restated the target price of $40.
uniQure N.V [QURE] stock has fluctuated between $4.45 and $19.18 over the past year. Currently, Wall Street analysts expect the stock to reach $37.33 within the next 12 months. uniQure N.V [NASDAQ: QURE] shares were valued at $16.18 at the most recent close of the market. An investor can expect a potential return of 130.72% based on the average QURE price forecast.
Analyzing the QURE fundamentals
uniQure N.V [NASDAQ:QURE] reported sales of 14.34M for the trailing twelve months, which represents a drop of -52.71%. Gross Profit Margin for this corporation currently stands at 0.83% with Operating Profit Margin at -11.81%, Pretax Profit Margin comes in at -13.76%, and Net Profit Margin reading is -13.88%. To continue investigating profitability, this company’s Return on Assets is posted at -0.34, Equity is -10.11 and Total Capital is -0.31. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-16.66.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.72 points at the first support level, and at 15.25 for the second support level. However, for the 1st resistance point, the stock is sitting at 16.65, and for the 2nd resistance point, it is at 17.12.
Ratios To Look Out For
For context, uniQure N.V’s Current Ratio is 9.98. Further, the Quick Ratio stands at 9.98, while the Cash Ratio is 6.2. Considering the valuation of this stock, the price to sales ratio is 61.91.
Transactions by insiders
Recent insider trading involved Abi-Saab Walid, Chief Medical Officer, that happened on Jun 27 ’25 when 1466.0 shares were sold. Director, Springhorn Jeremy P. completed a deal on Jun 20 ’25 to sell 2112.0 shares. Meanwhile, Director POST LEONARD E sold 2112.0 shares on Jun 20 ’25.
